Alnylam Pharmaceuticals shares owned by EntryPoint Capital
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by EntryPoint Capital
from 13F filings
Historical chart of EntryPoint Capital investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by EntryPoint Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $482k | 1.1k | 456.00 |
| 2025-06-30 | $505k | 1.6k | 326.09 |
| 2025-03-31 | $638k | 2.4k | 270.02 |
| 2024-12-31 | $598k | 2.5k | 235.31 |
| 2024-09-30 | $438k | 1.6k | 275.03 |